Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer’s Disease and Neurodegeneration: Old Drugs, New Concerns

Androgen deprivation therapy (ADT) is a standard treatment for prostate cancer patients, routinely used in the palliative or in the curative setting in association with radiotherapy. Among the systemic long-term side effects of ADT, growing data suggest a potentially increased risk of dementia/Alzhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Achard, Vérane, Ceyzériat, Kelly, Tournier, Benjamin B., Frisoni, Giovanni B., Garibotto, Valentina, Zilli, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712866/
https://www.ncbi.nlm.nih.gov/pubmed/34970480
http://dx.doi.org/10.3389/fonc.2021.734881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712866/
https://www.ncbi.nlm.nih.gov/pubmed/34970480
http://dx.doi.org/10.3389/fonc.2021.734881

Ejemplares similares